Methods for study of fluphenazine kinetics in man
- PMID: 12260
- DOI: 10.1111/j.2042-7158.1976.tb04082.x
Methods for study of fluphenazine kinetics in man
Abstract
Fluphenazine and its principal metabolites, fluphenazine sulphoxide, and 7-hydroxyfluphenazine were identified and quantified in human plasma, urine and faeces following intramuscular and oral administration of 14C-fluphenazine dihydrochloride. The presence of a conjugate fraction was also noted. Unmetabolized fluphenazine was selectively extracted into n-heptane. The metabolites were separated by solvent extraction into toluene. Conjugates were hydrolysed back to fluphenazine, fluphenazne sulphoxide and 7-hydroxyfluphenazine. Fluphenazine and fluphenazine conjugates were also measured in the urine of patients receiving long term non-radioactive fluphenazine decanoate therapy. The urinary excretion rate of the conjugate fraction was systematically related to the plasma concentration, regardless of urine flow rate or pH, providing a convenient method for the assessment of fluphenazine kinetics by urinary excretion studies not involving administration of labelled drug.
Similar articles
-
Clinical pharmacokinetics of the depot antipsychotics.Clin Pharmacokinet. 1985 Jul-Aug;10(4):315-33. doi: 10.2165/00003088-198510040-00003. Clin Pharmacokinet. 1985. PMID: 2864156 Review.
-
Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.Br J Clin Pharmacol. 1979 Apr;7(4):325-31. doi: 10.1111/j.1365-2125.1979.tb00941.x. Br J Clin Pharmacol. 1979. PMID: 444352 Free PMC article.
-
Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs.J Pharm Sci. 1976 Sep;65(9):1310-5. doi: 10.1002/jps.2600650912. J Pharm Sci. 1976. PMID: 966144
-
Excretion and biotransformation of the enanthate ester of fluphenazine- 14 C by the dog.J Pharm Sci. 1971 Jun;60(6):829-33. doi: 10.1002/jps.2600600606. J Pharm Sci. 1971. PMID: 5128931 No abstract available.
-
Depot fluphenazine: risk/benefit ratio.J Clin Psychiatry. 1984 May;45(5 Pt 2):28-35. J Clin Psychiatry. 1984. PMID: 6370986 Review.
Cited by
-
Plasma levels of fluphenazine during fluphenazine decanoate treatment in schizophrenia.Psychopharmacology (Berl). 1985;87(1):55-8. doi: 10.1007/BF00431778. Psychopharmacology (Berl). 1985. PMID: 3933037
-
Clinical pharmacokinetics of the depot antipsychotics.Clin Pharmacokinet. 1985 Jul-Aug;10(4):315-33. doi: 10.2165/00003088-198510040-00003. Clin Pharmacokinet. 1985. PMID: 2864156 Review.
-
Radioimmunoassay for fluphenazine in human plasma.Br J Clin Pharmacol. 1978 Mar;5(3):265-8. doi: 10.1111/j.1365-2125.1978.tb01636.x. Br J Clin Pharmacol. 1978. PMID: 566109 Free PMC article. No abstract available.
-
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate.Psychopharmacology (Berl). 1987;93(3):369-73. doi: 10.1007/BF00187259. Psychopharmacology (Berl). 1987. PMID: 3124166
-
Variation in the single dose pharmacokinetics of fluphenazine in psychiatric patients.Psychopharmacology (Berl). 1988;96(2):206-11. doi: 10.1007/BF00177561. Psychopharmacology (Berl). 1988. PMID: 3148147
MeSH terms
Substances
LinkOut - more resources
Full Text Sources